无声的征服:微型和纳米塑料通过儿童器官的旅程
Elena Esposito1, Francesco Fabrizio Comisi1, Vassilios Fanos1
1Neonatal Intensive Care Unit, Department of Surgical Sciences, AOU Cagliari, University of Cagliari, 09124 Cagliari, Italy.
Toxics
|October 28, 2025
概括
微型和纳米塑料 (MNP) 对儿童构成风险,对早期暴露的数据有限. 本综述综合了儿科MNP数据,突出了吸收途径和对儿童健康的潜在健康影响.
科学领域:
- 环境健康 环境健康
- 儿科毒理学 儿科毒理学
- 公共卫生 公共卫生
背景情况:
- 微型和纳米塑料 (MNP) 是普遍存在的环境污染物.
- 有证据表明MNP生物积累和人类潜在的毒性.
- 关于MNP暴露和健康风险的儿科数据很少.
研究的目的:
- 综合当前关于MNP在生命早期 (第1000天) 暴露的证据.
- 检查MNP吸收路径,分布和儿童器官特异性影响.
- 解决儿科MNP毒理学的关键知识差距.
主要方法:
- 关于儿科MNP暴露的现有文献的叙述性综述.
- 吸收途径的分析:口服,吸入,皮肤,阳性.
- 专注于儿童肺部,甲状腺和肠道微生物群中的MNP存在.
主要成果:
- 在婴儿和儿童中,MNP暴露通过多种途径发生.
- 发展儿科生理学具有独特的脆弱性.
- 潜在的长期健康影响包括内分泌干扰和神经发育障碍.
结论:
- 由于发育因素,儿童面临MNP暴露的风险增加.
- 进一步的研究对于了解和减轻MNP对儿科患者健康的影响至关重要.
- 本综述为临床医生和研究人员提供了关于儿科MNP暴露的全面资源.
相关概念视频
Types of Toxins
3.1K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Pharmacokinetics in Pediatric Patients: Drug Excretion
207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207


